NONOF Stock: Novo Nordisk A/S Stock Price, Analysis & Insights
Get live NONOF stock price $43.34, comprehensive Novo Nordisk A/S stock analysis, charts, news, and expert forecast. Real-time NONOF stock data and investment insights.
Loading chart data...
Novo Nordisk A/S (NONOF) Overview
Novo Nordisk A/S (NONOF) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, NONOF trades at $43.34 with a market capitalization of 192.55B . Over the past 52 weeks, NONOF has traded between $34.00 and $82.50 , with the current price positioned at approximately 19% of this range . The stock currently trades a...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 192.55B
- Current price: $43.34
- 52-week range: $34.00 - $82.50
- P/E ratio: 10.17
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Novo Nordisk A/S operates as a prominent global pharmaceutical firm, dedicated to the discovery, development, production, and distribution of a wide array of medicinal products. Its extensive operations are primarily structured into two distinct divi...
Company Information
- CEO
- Maziar Mike Doustdar
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 77406
Contact Information
- Website
- https://www.novonordisk.com
- Address
- Novo Allé 1
- Country
- DK
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 192.6 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 10.2)
✓ Lower volatility stock (Beta: 0.35) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Novo Nordisk A/S shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Novo Nordisk A/S
- ⚠Investors should consider how Novo Nordisk A/S fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
192.55B
P/E Ratio (TTM)
10.17
Beta
0.35
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare NONOF with peer companies:
- Price
- $189.90+0.00% (1D)
- Market cap
- 294.40B
- Price
- $73.80+9.25% (1D)
- Market cap
- 35.34B
- Price
- $17.91+2.69% (1D)
- Market cap
- 69.35B
- Price
- $202.80-1.15% (1D)
- Market cap
- 94.13B
- Price
- $10.93+0.92% (1D)
- Market cap
- 98.50B
- Price
- $144.88+0.00% (1D)
- Market cap
- 276.44B
- Price
- $414.00+1.22% (1D)
- Market cap
- 329.54B
- Price
- $50.42+0.56% (1D)
- Market cap
- 324.75B
- Price
- $411.25+0.00% (1D)
- Market cap
- 327.35B
- Price
- $20.58+1.81% (1D)
- Market cap
- 200.20B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
60/100 ⭐⭐⭐⭐
- Overall
- -1.4%
- NYSE
- -0.6%
- NASDAQ
- -2.2%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.2% | +1.6% | +1.7% | 19.1 | 100/100⭐⭐⭐⭐⭐ |
| Communication Services | -0.2% | -1.8% | +1.2% | 21.9 | 83/100⭐⭐⭐⭐⭐ |
| Energy | -0.2% | -6.1% | +1.5% | 37.0 | 75/100⭐⭐⭐⭐⭐ |
| Healthcare | -1.4% | -3.7% | -0.5% | 30.2 | 60/100⭐⭐⭐⭐ |
| Technology | -0.8% | -7.7% | +0.0% | 48.7 | 55/100⭐⭐⭐⭐ |
| Consumer Defensive | +0.7% | +3.0% | -1.6% | 31.1 | 50/100⭐⭐⭐ |
| Real Estate | -1.0% | -1.8% | -1.9% | 50.3 | 31/100⭐⭐ |
| Industrials | -2.7% | -7.6% | -2.1% | 41.5 | 30/100⭐⭐ |
| Basic Materials | -1.9% | -6.0% | -3.5% | 26.6 | 28/100⭐⭐ |
| Utilities | -2.1% | -6.9% | -8.5% | 25.3 | 24/100⭐ |
| Consumer Cyclical | -1.5% | -4.5% | -3.4% | 52.2 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score: 70% 1M momentum percentile + 30% valuation percentile (lower P/E ranks higher), shown as 0–100 with stars. Data as of 2026-06-11.